Organic Process Research & Development Outstanding Publication of the Year Lectureship Award
The Organic Process Research & Development Chemistry Outstanding Publication of the Year Lectureship Award will be awarded to the research team behind an outstanding article published in an issue of OPR&D in that demonstrates creativity and impact in the field of process chemistry and related disciplines associated with reaction scale-up. Special consideration will be given to early-career researchers as well as to the originality and impact of the article. For more information, see the Editorial for the Inaugural OPR&D Lectureship Award
Sponsorship of the Organic Process Research & Development Publication Award:
The award is sponsored by Organic Process Research & Development and the ACS Division of Organic Chemistry.
Nature of the Award:
The corresponding author of the recognized article will receive an 1) an award plaque, 2) an honorarium of US $2,000, 3) Registration and funding for travel and accommodations to attend and present at the upcoming National Organic Chemistry Symposium (NOS)
- Nominated articles must have been published in Organic Process Research & Development within the corresponding calendar year either in an issue or ASAP.
- Self-nominations are welcome.
- For the purpose of this award, “early career researcher” is defined as anyone no more than 10 years from the start of an independent academic, industry, or other research position. Anyone who has taken an official leave of absence may subtract that time from the limit.
- Current ACS Publications Editors-in-Chief, Deputy Editors, Executive Editors, Senior Editors, Associate Editors, and Topic Editors, and any serving selection committee member for this award are ineligible
Nominations and Additional Info:
See the 2024 Award Page (for publications in 2023). The nomination deadline is December 31, 2023
- 2023 – Jason Stevens and Colleagues at Bristol Myers Squibb for “Leveraging High-Throughput Experimentation to Drive Pharmaceutical Route Invention: A Four-Step Commercial Synthesis of Branebrutinib (BMS-986195)“
(These individuals were recognized at the 2023 NOS)
- Cecilia Bottecchia, Dan Lehnherr, and colleagues at Merck & Co. for “Kilo-Scale Electrochemical Oxidation of a Thioether to a Sulfone: A Workflow for Scaling up Electrosynthesis”
- Andrew Parsons and colleagues at Amgen for “Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor”
- James I. Murray, Liang Zhang, and colleagues at Amgen for “Kinetic and Mechanistic Investigations to Enable a Key Suzuki Coupling for Sotorasib Manufacture─What a Difference a Base Makes”
- Jennifer M. Elward at GlaxoSmithKline and colleagues for “Impact of Phosphine Featurization Methods in Process Development”